Anxiety medication can reshape measurable personality traits, and the changes sometimes go beyond simply dialing down worry. In a placebo-controlled trial using the SSRI paroxetine, patients showed shifts in neuroticism and extraversion that were four to eight times larger than what placebo patients experienced, even after statistically removing the drug’s effect on depression itself. That finding upended the assumption that personality changes during treatment are just a side effect of feeling less anxious. The reality is more layered, though, because different classes of anxiety medication interact with personality in very different ways, and what feels like a personality change to one person can feel like a restoration of their true self to another.
SSRIs and Measurable Personality Shifts
The most studied class of anxiety medication, selective serotonin reuptake inhibitors, appears to have a direct pharmacological effect on personality that operates independently of symptom relief. The key evidence comes from a trial that compared paroxetine to placebo in patients with major depression. Both groups improved, but paroxetine patients reported substantially greater drops in neuroticism and greater increases in extraversion. The researchers controlled for the degree of depression improvement and still found these personality effects, suggesting the drug was doing something to personality on its own rather than just lifting mood and letting pre-existing traits re-emerge.1JAMA Psychiatry. Personality Change During Depression Treatment: A Placebo-Controlled Trial
In practical terms, what this looked like for patients was a meaningful reduction in the tendency to experience negative emotions (the neuroticism dimension) paired with an increase in sociability and positive engagement with the world (extraversion). These are not subtle shifts visible only to researchers with questionnaires. People on SSRIs often describe themselves as less reactive to minor stressors, more willing to initiate social contact, and generally steadier in their emotional baseline. Whether you view that as a personality change or as personality correction depends heavily on your philosophical starting point, a tension we’ll return to later.
Changes in Social Behavior
The personality shifts from SSRIs extend into how you interact with other people in surprisingly specific ways. A study using citalopram in healthy volunteers found that their flatmates rated them as significantly less submissive after taking the drug. In structured social interactions with strangers, participants on citalopram displayed more dominant eye-contact patterns. At the same time, they also became more cooperative in economic games, awarding fewer points to themselves and sending more cooperative messages to other players.2PubMed. Serotonergic intervention affects both social dominance and affiliative behaviour
This combination is interesting because dominance and cooperation often seem like opposites. You might expect a drug that makes you more assertive to also make you more selfish. Instead, the serotonin boost seemed to produce people who were both more confident in social hierarchies and more generous in their dealings with others. The researchers interpreted this as serotonin modulating social status behavior broadly, not just flipping a single switch. If you’ve ever heard someone describe feeling “more like a normal person” on an SSRI, this kind of dual shift in assertiveness and warmth might be part of what they’re noticing.
Emotional Blunting and Who It Affects
One of the most common complaints about anxiety medication is emotional blunting, the feeling that your highs are lower and your lows are less painful, leaving you in a muted middle zone. This is a real experience for some patients, and it deserves to be taken seriously. But the research picture is more nuanced than the popular narrative suggests.
A study that gave SSRIs to healthy elderly volunteers with no psychiatric conditions found no significant changes in personality, affect, emotional lability, daily mood, or affective variability.3The American Journal of Geriatric Psychiatry. SSRIs Do Not Cause Affective Blunting in Healthy Elderly Volunteers The researchers could even calculate upper limits on how much blunting might be occurring based on confidence intervals, and the potential effect was small. This suggests that the emotional flattening some patients report is likely tied to an interaction between the drug and their underlying condition rather than being a universal pharmacological effect of SSRIs on all brains.
For someone whose baseline emotional life is dominated by anxiety, reducing the volume on negative emotions might initially feel like losing access to all emotions. Over weeks, many patients report that positive emotions return while the anxious static stays quieter. Others, though, find the blunting persistent and distressing enough to switch medications. The individual variation here is enormous, and current science cannot reliably predict who will experience blunting before treatment begins.
How Benzodiazepines Differ
Benzodiazepines like lorazepam, alprazolam, and diazepam work on an entirely different system than SSRIs, enhancing the brain’s primary inhibitory neurotransmitter rather than modifying serotonin levels. Their personality effects are correspondingly different. Rather than gradually shifting trait-level characteristics over weeks, benzodiazepines produce rapid changes in state: reduced vigilance, lower inhibition, and a general dampening of emotional reactivity that starts within an hour of taking the pill.
The personality concern with benzodiazepines is less about subtle trait shifts and more about behavioral disinhibition and dependence. Regular use has been shown to cause severe psychological and physical dependence, producing withdrawal symptoms that resemble alcohol withdrawal.4PubMed Central. Benzodiazepines: Uses, Dangers, and Clinical Considerations When someone becomes dependent, the medication becomes woven into their emotional baseline in a way that makes it genuinely difficult to separate drug effects from personality. People who have been on benzodiazepines for years sometimes describe feeling like they don’t know who they are without the drug, a qualitatively different experience from the “becoming more yourself” narrative that often accompanies SSRI use.
There’s also a more immediate behavioral concern. Because benzodiazepines reduce anxiety and lower inhibition simultaneously, they can produce a state where someone makes choices they wouldn’t normally make, not because their values have changed but because the emotional brake that usually stops impulsive behavior is weaker. This is the same mechanism that makes alcohol disinhibiting, and it carries similar risks in social and interpersonal situations.
Shifts in Moral Reasoning
Perhaps the most philosophically unsettling finding in this area involves how anxiety medication alters moral decision-making. In experiments using hypothetical moral dilemmas, the kind where you have to decide whether to sacrifice one person to save five, different medications pushed people in opposite directions.
Citalopram, an SSRI, made healthy volunteers more likely to judge harmful actions as forbidden, but only when the harm was emotionally vivid and personal. It also made them less likely to reject unfair offers in economic games, because rejecting an unfair offer punishes the other player financially. People high in trait empathy showed even stronger effects. The researchers framed this as serotonin enhancing harm aversion, a prosocial shift that makes you more reluctant to cause direct suffering to another person.5PubMed Central. Serotonin selectively influences moral judgment and behavior through effects on harm aversion
Lorazepam, a benzodiazepine, had the opposite effect on personal moral dilemmas. Participants given lorazepam were more willing to endorse personally harming someone when the scenario involved a direct physical act, compared to those on placebo. The drug did not change responses to impersonal dilemmas where the harm was more abstract.6Scientific Reports. Negative emotionality downregulation affects moral choice but not moral judgement of harm: a pharmacological study The interpretation is straightforward: benzodiazepines reduce the emotional discomfort that normally accompanies the thought of directly hurting someone, making it easier to endorse that action in the abstract.
These are laboratory findings using hypothetical scenarios, not evidence that SSRIs make you a saint or that benzodiazepines make you dangerous. But they do reveal that anxiety medications can alter the emotional inputs that feed into moral reasoning, which is worth knowing if you’re curious about whether your medication is affecting your judgment in ways that extend beyond anxiety itself.
The Authenticity Paradox
People on anxiety medication frequently grapple with a question that rarely comes up with, say, blood pressure medication: is this still me? The research on this question reveals a genuine paradox. Some patients report that psychotropic drugs cause experiences of authenticity, making them feel “like themselves” for the first time in their lives. Medication lifts a fog they didn’t realize was there, and the personality that emerges feels more genuine than what came before.7PubMed Central. Authenticity Anyone? The Enhancement of Emotions via Neuro-Psychopharmacology
But research also shows an inherent contradiction in how people process this experience. Most respondents in qualitative studies believe medication is necessary, yet taking a mood-modifying drug is simultaneously perceived as a potential threat to personal agency and the achievement of an authentic self.8PubMed. Discourses of agency and the search for the authentic self: the case of mood-modifying medicines People want the medication to work but also want to believe they are actively choosing who they become, not having it chemically selected for them.
This tension is not resolvable through pharmacology alone. If anxiety has been a dominant feature of your personality for decades, treatment may reveal traits that were always there but suppressed, in which case the medication is peeling away a mask rather than imposing one. If, on the other hand, the medication produces a version of you that your friends and family find unrecognizable, the personality change may be genuinely iatrogenic. The subjective experience from the inside does not always distinguish between these two scenarios clearly, which is why regular check-ins with people who know you well matter during treatment.
Buspirone, Beta-Blockers, and Other Options
Not all anxiety medications are SSRIs or benzodiazepines, and the alternatives have their own personality profiles. Buspirone, which works on serotonin receptors differently than SSRIs and is approved specifically for generalized anxiety disorder, has anxiolytic effects that in behavioral studies resemble those of benzodiazepines but through different mechanisms.9PubMed. Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior However, buspirone does not carry the same dependence risk, and patients generally report less cognitive dulling and emotional blunting than with either SSRIs or benzodiazepines. Its personality effects, in practice, tend to be subtler: people describe feeling somewhat calmer and less hypervigilant without a dramatic shift in who they feel they are.
Beta-blockers like propranolol sit in a different category entirely. They primarily target the physical symptoms of anxiety, including rapid heartbeat, trembling, and sweating, without significantly altering mood or cognition at standard doses. In physiological studies, propranolol significantly reduced heart rate but did not produce meaningful changes in subjective arousal or mood measures.10Psychopharmacology. Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers For people whose anxiety is primarily physical, particularly in performance contexts like public speaking, beta-blockers can feel like they change personality by removing the physical barrier to confident behavior. But the mechanism is entirely peripheral. Your thoughts and emotional patterns stay the same; your body just stops broadcasting panic signals.
On the newer end, ketamine and its derivatives are being explored for treatment-resistant conditions. Early evidence suggests that personality traits may predict who responds well. One study found that the personality dimension of openness to experience was the only factor to significantly predict sustained treatment outcomes with ketamine.11PubMed. The NEO-FFI domain of openness to experience moderates ketamine response in treatment resistant depression This is a different kind of personality finding: rather than the drug changing personality, the patient’s pre-existing personality determines whether the drug works. It raises the possibility that personality matching could eventually help clinicians choose between medications, though the science is not there yet.
Your Personality Also Shapes How the Drug Feels
The relationship between anxiety medication and personality runs in both directions. A systematic review examining personality traits and placebo and nocebo responses found that optimism was positively associated with stronger placebo responses, while higher anxiety was associated with increased nocebo effects, meaning anxious people were more likely to experience side effects even from an inert pill.12Journal of Psychosomatic Research. The influence of personality traits on the placebo/nocebo response: A systematic review This means that the very trait you’re trying to treat, anxiety, may amplify your perception of negative changes during treatment.
In practical terms, this creates a confusing feedback loop. An anxious person starts medication, monitors themselves hypervigilantly for changes (because that’s what anxious people do), notices something different, attributes it to the drug, becomes anxious about the drug, and experiences more side effects partly driven by that anxiety. Clinicians who work with anxious patients know this pattern well. It doesn’t mean the side effects aren’t real, but it does mean that the personality changes you notice during the first weeks of treatment are particularly unreliable as indicators of what the long-term experience will be like.
The Question of “Cosmetic” Use
In 1993, psychiatrist Peter Kramer coined the term “cosmetic psychopharmacology” in his bestseller Listening to Prozac to describe using psychoactive drugs to improve functioning in people who are technically normal. The concept raised questions that remain unresolved: What separates clinical depression from normal sadness? Where does anxious temperament end and anxiety disorder begin? If the boundaries are blurry, how do we know whether prescribing an SSRI to someone with subclinical anxiety counts as treatment or enhancement?13PubMed. Can there be a ‘cosmetic’ psychopharmacology? Prozac unplugged: the search for an ontologically distinct cosmetic psychopharmacology
These questions matter because the personality effects of SSRIs documented in research, reduced neuroticism, increased extraversion, greater assertiveness and cooperation, sound like things most people would want regardless of whether they have a diagnosable condition. The study showing that paroxetine shifts personality independently of depression improvement makes the cosmetic possibility harder to dismiss.14JAMA Psychiatry. Personality Change During Depression Treatment: A Placebo-Controlled Trial If the drug acts directly on personality traits rather than just clearing away pathology, the line between treatment and enhancement gets genuinely hard to draw.
In practice, most clinicians prescribe anxiety medication to people who are suffering, and the personality changes are welcomed as part of recovery. But the theoretical possibility that these drugs could be used to optimize personality in healthy people raises ethical stakes that go well beyond the doctor’s office. It touches questions about what counts as a fair advantage in competitive environments, whether pharmaceutical personality changes are equivalent to changes achieved through therapy or meditation, and who gets to define what a “normal” personality looks like in the first place. These are not questions pharmacology can answer, but pharmacology is the reason they now need asking.